TY - JOUR
T1 - Synthesis and Antitumor Activity of Fused Tetracyclic Quinoline Derivatives
AU - Yamato, Masatoshi
AU - Takeuchi, Yasuo
AU - Hashigaki, Kuniko
AU - Ikeda, Yuji
AU - Ming-rong, Chang
AU - Takeuchi, Kyoko
AU - Matsushima, Mayumi
AU - Tsuruo, Takashi
AU - Tashiro, Tazuko
AU - Tsukagoshi, Shigeru
AU - Yamashita, Yoshinori
AU - Nakano, Hirofumi
PY - 1989/6/1
Y1 - 1989/6/1
N2 - Several fused tri- and tetracyclic quinolines (I and II) with [2-methoxy-4-[(methylsulfonyl)amino] phenyl]amino or [3-(N,N-dimethylaminb)propyl]amino side chains were prepared, and their DNA intercalative properties, KB cytotoxicity, antitumor activity (P388 leukemia), and ability to induce topoisomerase II dependent DNA cleavage were investigated. Some compounds having both intercalative ability and KB cytotoxicity were found to be inactive in vivo. However, a positive correlation was seen between the ability to induce topoisomerase II dependent DNA cleavage and antitumor activity in vivo. The indeno- (13a), benzofuro- (21a), and benzothieno- (22a) quinoline derivatives exhibited potent antitumor activities in vitro and in vivo, comparable to those of m-AMSA. They also intercalate DNA and induce topoisomerase II dependent DNA cleavage. Extended screening of 13a showed it to be active against solid tumors such as M5076 sarcoma, B16 melanoma, and colon 38 carcinoma.
AB - Several fused tri- and tetracyclic quinolines (I and II) with [2-methoxy-4-[(methylsulfonyl)amino] phenyl]amino or [3-(N,N-dimethylaminb)propyl]amino side chains were prepared, and their DNA intercalative properties, KB cytotoxicity, antitumor activity (P388 leukemia), and ability to induce topoisomerase II dependent DNA cleavage were investigated. Some compounds having both intercalative ability and KB cytotoxicity were found to be inactive in vivo. However, a positive correlation was seen between the ability to induce topoisomerase II dependent DNA cleavage and antitumor activity in vivo. The indeno- (13a), benzofuro- (21a), and benzothieno- (22a) quinoline derivatives exhibited potent antitumor activities in vitro and in vivo, comparable to those of m-AMSA. They also intercalate DNA and induce topoisomerase II dependent DNA cleavage. Extended screening of 13a showed it to be active against solid tumors such as M5076 sarcoma, B16 melanoma, and colon 38 carcinoma.
UR - http://www.scopus.com/inward/record.url?scp=0024361825&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024361825&partnerID=8YFLogxK
U2 - 10.1021/jm00126a025
DO - 10.1021/jm00126a025
M3 - Article
C2 - 2542558
AN - SCOPUS:0024361825
SN - 0022-2623
VL - 32
SP - 1295
EP - 1300
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 6
ER -